A new article from the EPAD consortium entitled “Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort” has recently been published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. In this article, the ATN classification was operationalized in the first 1500 participants consented in the EPAD…
DetailsThe European Prevention of Alzheimer’s Dementia (EPAD) consortium, in their partnership with Aridhia, are proud to announce that the EPAD V.IMI dataset has been incorporated into the Alzheimer’s Disease Workbench to provide even greater value to the global neuroscience research community. The latest and final EPAD dataset went into open access to all researchers from…
DetailsA key achievement of the EPAD project was the establishment of a Longitudinal Cohort Study (LCS) that has screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data to help further our understanding of the early stages of Alzheimer’s disease. EPAD has made this database open access and publicly…
DetailsAlzheimer Europe has published a new edition of its “Dementia in Europe” policy magazine, in an electronic format. The first section of the magazine includes a closing article on the EPAD project in which Alzheimer Europe has been involved. Our co-leads Craig Ritchie and Serge Van der Geyten have been interviewed and reflect on the…
DetailsAt an online European Parliament workshop hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe launched a new report “Data Sharing in Dementia Research”, which reviews recent changes in EU research policy and sets out recommendations to improve data sharing in dementia research. In this report, Alzheimer Europe evaluates the legal and policy landscapes that dementia…
DetailsOn 17 February, we were pleased to hold the first local EPAD community meeting among the Scottish research sites, collaborators, academics and scientists who have been involved in the EPAD Longitudinal Cohort Study (LCS) throughout the IMI funded period and now continue to contribute to the study locally. The first local EPAD community meeting focused…
DetailsOn 1 February, the members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme announced the launch of a pan-European Knowledge Base which brings together key information about the 18 projects of the Innovative Medicines Initiative (IMI) neurodegeneration (ND) portfolio, including the EPAD project. This comprehensive resource is an integral part of Neuronet’s endeavour to…
DetailsThe European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the external release of its final dataset for all researchers from over the world. The final dataset is called Version.IMI (V.IMI) as it represents all the data collected and processed during the IMI period of EPAD. A key achievement of the EPAD…
DetailsA conference blog about the 13th Clinical Trials on Alzheimer’s Disease (CTAD) conference which took online, from 4-7 November 2020, has been published on the AlzForum website. The article mentions EPAD and can be read below: EPAD had been supported for five years by the Innovative Medicines Initiative (IMI), which is funded jointly by the…
DetailsA key achievement of the EPAD project was the establishment of a Longitudinal Cohort Study (LCS) that has screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data to help further our understanding of the early stages of Alzheimer’s disease. “We aim to ensure that this precious collection of…
Details
